The Food and Drug Administration is expected to authorize the use of the Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12 to 15 by early next week, according to a new report.
The authorization could come as soon as the end of this week, the New York Times reported on Monday. If the FDA gives the green light, the Centers…
Connect with us on our socials: